Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia
Brief Summary:
The purpose of the study is to evaluate the safety and tolerability of pegylated interferon alpha-2b (PEG-Intron) in patients with severe complications related to Hereditary hemorrhagic telangiectasia (HHT).
Funding Source - FDA Office of Orphan Products Development (OOPD)